4AB:FRA
AbbVie Common Stock
€252.50
arrow_downward
-0.59%(-1.50) 1D
Oct 23, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€253.20
High
€256.00
Low
€252.50
Mkt. cap
504.76B
Avg. vol.
82.00
Volume
4.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57K
Open
€253.20
High
€256.00
Low
€252.50
Mkt. cap
504.76B
Avg. vol.
82.00
Volume
4.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
Investing.com
·
6 hours ago
AbbVie shares may move 5% on Oct. 30 earnings release
Yahoo Finance
·
7 hours ago
BMY vs. ABBV: Which Pharma/Biotech Stock Offers More Upside Potential?
MedWatch
·
10 hours ago
Gubra partner AbbVie hits main goal in skin disease trial, plans to pair drug with weight-loss candidate
The Motley Fool
·
20 hours ago
What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and Pfizer
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com